Avalyn Pharma Inc. Common Stock
NASDAQ:AVLNMedical - Pharmaceuticals
+$0.52 today
- Market cap
- $1.23B
- Beta
- 0.00
Volume 0.40M
Average 0.51M
AVLN Income Before Tax
Profit after all operating and non-operating items but before income tax.
Income Before Tax history
Currency unavailable · from the income statement
No Income Before Tax data reported for this period type.
Income Before Tax vs competitors
How AVLN compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $564K USD | -96.3% | +15.3% | 0.5% | |
| LTM Mar 2026 | -$28.58M USD | -186.0% | — | 7.9% | |
VCREVicore Pharma Holding AB | LTM Jun 2026 | -SEK 272.4M SEK | +30.8% | — | 20481.7% |
| LTM Jun 2026 | -$869.11M USD | +15.6% | — | 76.4% | |
AVLNAvalyn Pharma Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding AVLN) | — | -40.4% | +15.3% | 42.2% | |
Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN
Intrinsic Alpha fair value
Locked
Current Price
$27.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.